Gene editing and many other useful biotechnology tools came from studies of bacteria fighting off viral invaders. But ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...